Submission Details
| 510(k) Number | K183571 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 21, 2018 |
| Decision Date | February 04, 2019 |
| Days to Decision | 45 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K183571 is an FDA 510(k) clearance for the Capture-CMV, a Antigen, Iha, Cytomegalovirus (Class II — Special Controls, product code LJO), submitted by Immucor, Inc. (Norcross, US). The FDA issued a Cleared decision on February 4, 2019, 45 days after receiving the submission on December 21, 2018. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3175.
| 510(k) Number | K183571 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | December 21, 2018 |
| Decision Date | February 04, 2019 |
| Days to Decision | 45 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LJO — Antigen, Iha, Cytomegalovirus |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3175 |